Who owns MOLECULIN BIOTECH INC?
- CUSIP Number: 60855d200
Tip: Access positions for across all investors
Analyze quarterly positions in Moleculin Biotech with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Moleculin Biotech stock
Who bought or sold MOLECULIN BIOTECH INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Vanguard Group | 1.1M | $927k | 0% | Dec 2023 |
|
Citadel Advisors | 65k | $56k | 100% | Dec 2023 |
|
P.J. Schmidt Investment Management | 29k | $14k | 0% | Dec 2023 |
|
Royal Bank of Canada | 20k | $0 | 6420% | Dec 2023 |
|
Jmac Enterprises | 13k | $11k | 0% | Dec 2023 |
|
Sigma Planning | 12k | $10k | -29% | Dec 2023 |
|
Sandy Spring Bank | 1.3k | $1.1k | 100% | Dec 2023 |
|
Advisor Group Holdings | 968.00 | $831.802400 | 0% | Dec 2023 |
|
CVA Family Office | 500.00 | $429.000000 | 100% | Dec 2023 |
|
North Star Investment Management | 250.00 | $215.000000 | 0% | Dec 2023 |
|
Wells Fargo & Company | 229.00 | $197.008700 | -68% | Dec 2023 |
|
Bank of America Corporation | 138.00 | $118.279800 | 38% | Dec 2023 |
|
Hazlett, Burt & Watson | 67.00 | $0 | 100% | Dec 2023 |
|
Jpmorgan Chase & Co | 52.00 | $45.000800 | 44% | Dec 2023 |
|
Who sold out of Moleculin Biotech?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Atticus Wealth Management | Dec 2023 | 50k | $43k |
Millennium Management | Sep 2023 | 31k | $13k |
UBS Group | Sep 2023 | 200.00 | $85.000000 |